Donald Trump, AP (Photo by: Dennis Van Tine/STAR MAX/IPx 2020)

As Trump touts his ‘great’ Covid drugs, the phar­ma cash flows to Biden, not him

Phar­ma­ceu­ti­cal gi­ants Re­gen­eron and Gilead Sci­ences got the kind of pub­lic­i­ty mon­ey can’t buy this week af­ter Pres­i­dent Don­ald Trump took their ex­per­i­men­tal drugs for his coro­n­avirus in­fec­tion, left the hos­pi­tal and pro­nounced him­self ful­ly re­cov­ered.

“It was, like, un­be­liev­able. I felt good im­me­di­ate­ly,” Trump said Wednes­day in a tweet­ed video. “I call that a cure.”

He praised Re­gen­eron’s mon­o­clon­al an­ti­body cock­tail, which mim­ics el­e­ments of the im­mune sys­tem, and men­tioned a sim­i­lar drug un­der in­ves­ti­ga­tion by Eli Lil­ly and Co. The pres­i­dent al­so took Gilead’s remde­sivir, an an­tivi­ral that has short­ened re­cov­ery times for Covid-19 pa­tients in ear­ly re­search.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.